VUTRISIRAN SODIUM | ALNYLAM PHARMS INC | ||
EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) | |||
No | No | ||
2036-Jul-28 | 2027-Jun-13 | ||
None | None | ||
None | No | ||
AMVUTTRA is a transthyretin-directed small interfering RNA indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. |
0 | 0 | 0 |
Total Other Developers | None |
---|
Drugs with Suitability | No |
---|
EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) | ** | ** | - | - | - |
NDA Sales Available | Total Generic Sales Available |
---|---|
Yes | 0 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com